CAUSES OF IMPLANTATION FAILURE AFTER IN-VITRO FERTILISATION AND EMBRYO TRANSFER

The Lancet

Volumn 326, Issue 8455, 1985, Pages 615-

  O'Neill, C ^a   Ferrier, A J ^a   Vaughan, J ^a   Sinosich, M J ^a   Saunders, D M ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN;

ADULT; CLINICAL ARTICLE; EMBRYO; EMBRYO TRANSFER; ENDOCRINE SYSTEM; ETIOLOGY; FAILURE; FATALITY; FEMALE GENITAL SYSTEM; FERTILIZATION IN VITRO; HUMAN; IMPLANTATION; LUTEAL PHASE; PREGNANCY; PREGNANCY RATE; PRIORITY JOURNAL; SUPPORT; THERAPY;

EMBRYO IMPLANTATION; EMBRYO TRANSFER; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; HUMANS; PREGNANCY; PROGESTERONE;

EID: 0022006309     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(85)90615-4     Document Type: Letter

References (9)

1. Embryo quality and pregnancy rates in in-vitro fertilisation
2. The quality of embryos from in-vitro fertilisation
3. Assessment of embryo quality
4. Maternal blood platelet physiology and luteal-phase endocrinology as a means of monitoring pre- and peri-implantation embryo viability following in-vitro fertilization
5. Corpus luteum function after follicle aspiration for oocyte retrieval
6. Interception: The use of post ovulatory estrogens to prevent implantation
7. Progesterone inhibition of nuclear estrogen receptor: Dependence on RNA and protein synthesis
8. Thrombocyopenia is an initial maternal response to pregnancy in mice